Observational Study on Safety and Efficacy of NovoSeven® in Subjects With Congenital FVII Deficiency

NCT01312636 · clinicaltrials.gov ↗

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Bleeding Disorder
Congenital FVII Deficiency

Interventions

DRUG: activated recombinant human factor VII

Sponsor

Novo Nordisk A/S